chr22-38706110-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004286.5(GTPBP1):c.155C>T(p.Ala52Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000253 in 1,304,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004286.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTPBP1 | ENST00000216044.10 | c.155C>T | p.Ala52Val | missense_variant | 1/12 | 1 | NM_004286.5 | ENSP00000216044.5 | ||
GTPBP1 | ENST00000484657.5 | c.-52+293C>T | intron_variant | 4 | ENSP00000442881.1 | |||||
GTPBP1 | ENST00000418601.1 | n.155C>T | non_coding_transcript_exon_variant | 1/4 | 2 | ENSP00000397891.1 | ||||
GTPBP1 | ENST00000461428.1 | n.-8C>T | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152092Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000269 AC: 31AN: 1152702Hom.: 0 Cov.: 31 AF XY: 0.0000306 AC XY: 17AN XY: 555426
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152092Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.155C>T (p.A52V) alteration is located in exon 1 (coding exon 1) of the GTPBP1 gene. This alteration results from a C to T substitution at nucleotide position 155, causing the alanine (A) at amino acid position 52 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at